FCH
AVXL icon

Freestone Capital Holdings’s Anavex Life Sciences AVXL Stock Holding History

Freestone Capital Holdings’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,000
Closed -$178K – 562
2025
Q3 		$178K Hold
20,000
– – 0.01% 513
2025
Q2 		$184K Hold
20,000
– – 0.01% 434
2025
Q1 		$172K Hold
20,000
– – 0.01% 428
2024
Q4 		$215K Hold
20,000
– – 0.01% 416
2024
Q3 		$114K Buy
20,000
+6,200
+45% +$35.8K ﹤0.01% 422
2024
Q2 		$58.2K Hold
13,800
– – ﹤0.01% 452
2024
Q1 		$70.2K Hold
13,800
– – ﹤0.01% 433
2023
Q4 		$128K Hold
13,800
– – 0.01% 383
2023
Q3 		$90.4K Buy
13,800
+3,800
+38% +$30.2K ﹤0.01% 356
2023
Q2 		$81.3K Buy
+10,000
New +$85.7K ﹤0.01% 370

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $1.74B AUM 32.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return